Augmedix downgraded by Maxim Group with a new price target
$AUGX
Business Services
Consumer Discretionary
Maxim Group downgraded Augmedix from Buy to Hold and set a new price target of $5.00
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 7/22/2024 | Buy → Hold | Lake Street | |
| 7/22/2024 | $3.00 → $2.35 | Buy → Neutral | B. Riley Securities |
| 5/14/2024 | $5.00 | Buy → Hold | Maxim Group |
| 5/14/2024 | $5.00 → $1.50 | Outperform → In-line | Evercore ISI |
| 4/3/2024 | $5.50 | Buy | B. Riley Securities |
| 12/15/2023 | $6.00 | In-line | Evercore ISI |
| 3/7/2022 | $6.00 | Buy | Lake Street |
| 1/21/2022 | $6.00 | Buy | Maxim Group |
4 - Augmedix, Inc. (0001769804) (Issuer)
4 - Augmedix, Inc. (0001769804) (Issuer)
4 - Augmedix, Inc. (0001769804) (Issuer)
4 - Augmedix, Inc. (0001769804) (Issuer)
4 - Augmedix, Inc. (0001769804) (Issuer)
15-12G - Augmedix, Inc. (0001769804) (Filer)
EFFECT - Augmedix, Inc. (0001769804) (Filer)
EFFECT - Augmedix, Inc. (0001769804) (Filer)